Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Fetus and Newborn”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)Study completedNCT00001197
What this trial is testing

Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia

Who this might be right for
Sickle Cell Anemia
National Heart, Lung, and Blood Institute (NHLBI) 41
Not applicableNot Yet RecruitingNCT07371520
What this trial is testing

Application of Quantitative Hemorrhage Detection in Fetomaternal Hemorrhage Syndrome for the Diagnosis of Hemolytic Disease of the Newborn

Who this might be right for
Hemolytic Disease of the Newborn
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100
Early research (Phase 1)Looking for participantsNCT01245179
What this trial is testing

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Abdullah Kutlar 18
Not applicableStudy completedNCT03755128
What this trial is testing

Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn

Who this might be right for
Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)Erythroblastosis, Fetal
Janssen Research & Development, LLC 17
Testing effectiveness (Phase 2)Study completedNCT03842189
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Who this might be right for
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC 25
Not applicableStudy completedNCT01715480
What this trial is testing

Effect of Broccoli Sprouts Homogenate on SS RBC

Who this might be right for
Sickle Red Blood CellFetal HemoglobinOxidative Stress
Duke University 21
Not applicableLooking for participantsNCT06984445
What this trial is testing

Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia

Who this might be right for
s100bHypoxia-Ischemia, BrainHemolytic Disease of the Fetus and Newborn+1 more
Institute of Mother and Child, Warsaw, Poland 180
Not applicableUnknownNCT05617612
What this trial is testing

Neonatal Cord Blood Screening for HDN

Who this might be right for
HDN - Hemolytic Disease of the Newborn
Assiut University 400
Early research (Phase 1)Study completedNCT01522547
What this trial is testing

Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease

Who this might be right for
Anemia, Sickle Cell
Celgene 12
Testing effectiveness (Phase 2)Looking for participantsNCT06490627
What this trial is testing

Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia

Who this might be right for
Fetal HemoglobinThalassemia MajorGenetic Disease
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 54
Early research (Phase 1)Ended earlyNCT02986698
What this trial is testing

In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)

Who this might be right for
Alpha Thalassemia MajorHemoglobinopathy; With ThalassemiaHemoglobinopathies+6 more
University of California, San Francisco 6
Testing effectiveness (Phase 2)Study completedNCT00001958
What this trial is testing

Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)

Who this might be right for
Beta ThalassemiaHemoglobinopathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100
Large-scale testing (Phase 3)UnknownNCT03104426
What this trial is testing

EPO-4-Rhesus Study

Who this might be right for
Erythroblastosis, FetalErythroblastosis Fetalis, Rh DiseaseErythroblastosis Fetalis Due to RH Antibodies+1 more
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research 42
Not applicableStudy completedNCT04802629
What this trial is testing

Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.

Who this might be right for
Preterm BirthOxygen ToxicityFetal Hemoglobin
Medical University of Graz 50
Not applicableUnknownNCT05788562
What this trial is testing

The Relevance Between the Level of Fetal Hemoglobin and Short-term Complications in Extremely Preterm Infants

Who this might be right for
Fetal Hemoglobin
The First Hospital of Jilin University 92
Not applicableLooking for participantsNCT07194070
What this trial is testing

A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

Who this might be right for
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC 175
Not applicableNot Yet RecruitingNCT07502781
What this trial is testing

Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants

Who this might be right for
Extremely Premature InfantAnemia NeonatalBlood Transfusion+6 more
Hospital Clinic of Barcelona 176
Testing effectiveness (Phase 2)Ended earlyNCT01000155
What this trial is testing

Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT06490601
What this trial is testing

Long Term Beta Thalassemia Treatment: Findings From The Extension Period

Who this might be right for
Fetal HemoglobinBeta-ThalassemiaHemoglobinopathies
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 30
Large-scale testing (Phase 3)Looking for participantsNCT05912517
What this trial is testing

Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Who this might be right for
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC 120
Next Page